Cytowanie według stylu APA (wyd. 7)

Nyman, H., Jerkeman, M., Karjalainen-Lindsberg, M., Banham, A., Enblad, G., & Leppa, S. (2008). BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas.

Cytowanie według stylu Chicago (wyd. 17)

Nyman, H., M. Jerkeman, M. Karjalainen-Lindsberg, A. Banham, G. Enblad, i S. Leppa. BCL-2 but Not FOXP1, Is an Adverse Risk Factor in Immunochemotherapy Treated Non-germinal Center Diffuse Large B-cell Lymphomas. 2008.

Cytowanie według stylu MLA (wyd. 9)

Nyman, H., et al. BCL-2 but Not FOXP1, Is an Adverse Risk Factor in Immunochemotherapy Treated Non-germinal Center Diffuse Large B-cell Lymphomas. 2008.